Humoral Derived SARS-CoV-2 Nucleocapsid Protein Specific Combinatorial Single Domain Antibodies
NB Dlamini, CH Lee, WC Wang, PN Huang… - Available at SSRN … - papers.ssrn.com
Combinatorial single domain monoclonal antibody (sdAb) fragments are integral
monoengineered biophysical molecules in immunomolecular applications. Camelids such …
monoengineered biophysical molecules in immunomolecular applications. Camelids such …
[PDF][PDF] State-of-the-art preclinical evaluation of COVID-19 vaccine candidates
B Bai, Q Ji, S Palliyil, G Yang, A Kumar… - Exploration of …, 2021 - aura.abdn.ac.uk
Abstract The coronavirus disease 2019 (COVID-19) results from the infection of severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) and primarily affects the respiratory …
respiratory syndrome coronavirus-2 (SARS-CoV-2) and primarily affects the respiratory …
[PDF][PDF] Article type: Short communication Title: Neutralization of European, South African, and United States SARS-CoV-2 mutants by a human antibody and antibody …
Z Sun, A Kim, MD Sobolewski, N Enick, C Chen… - researchgate.net
Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) transmission
with several emerging variants remain uncontrolled in many countries, indicating the …
with several emerging variants remain uncontrolled in many countries, indicating the …
[图书][B] Interrogating a New HIV-1 Vaccine Target in the GP41 C-Heptad Repeat
BN Bell - 2021 - search.proquest.com
HIV-1 infection requires viral and cell membrane fusion, a process which relies on the gp41
N-heptad repeat (NHR) and C-heptad repeat (CHR) of the viral glycoprotein Env. When the …
N-heptad repeat (NHR) and C-heptad repeat (CHR) of the viral glycoprotein Env. When the …
[PDF][PDF] Indonesian Archives of Biomedical Research
W Hidayati, RD Antarianto - researchgate.net
For several decades ago, passive immunization has already proven its ability to treat some
diseases, especially pandemic diseases. On the contrary, after antibiotics discovery, the …
diseases, especially pandemic diseases. On the contrary, after antibiotics discovery, the …
The Role of artificial intelligence in designing antibody-based therapy for Covid-19
W Hidayati, RD Antarianto - Indonesian Archives of …, 2021 - garuda.kemdikbud.go.id
For several decades ago, passive immunization has already proven its ability to treat some
diseases, especially pandemic diseases. On the contrary, after antibiotics discovery, the …
diseases, especially pandemic diseases. On the contrary, after antibiotics discovery, the …
[PDF][PDF] Cryo-EM Structures of the N501Y SARS-CoV-2 Spike Protein in Complex with ACE2 and Two Potent Neutralizing Antibodies
JW Demers, K Leopold, W Li, DS Dimitrov, S Katharine… - scholar.archive.org
The recently reported “UK variant” of SARS-CoV-2 is thought to be more infectious than
previously circulating strains as a result of several changes, including the N501Y mutation …
previously circulating strains as a result of several changes, including the N501Y mutation …
Anti-coronavirus antibodies and methods of use
K WESTENDORF, S ZENTELIS, K MUTHURAMAN… - 2021 - Google Patents
WO2021183195A1 - Anti-coronavirus antibodies and methods of use - Google Patents
WO2021183195A1 - Anti-coronavirus antibodies and methods of use - Google Patents Anti-coronavirus …
WO2021183195A1 - Anti-coronavirus antibodies and methods of use - Google Patents Anti-coronavirus …